BCL2L1 and lung carcinoma: Nuclear PI staining, followed by flow cytometry, revealed that inhibiting Bcl-xL with Abt737 plus VNR contributed to more apoptosis in A549 and CL1-5 lung cancer cells than VNR alone (P < 0.05) (Figure 4C).